Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Number needed to treat: solid science or a path to pernicious rationing?

H R Black1, M T Crocitto

  • 1Rush-Presbyterian-St. Luke's Medical Center, Rush Medical College, Chicago, Illinois, USA.

American Journal of Hypertension
|August 26, 1998
PubMed
Summary

Clinical trial data may not reflect real-world outcomes, leading to suboptimal patient care. Effectiveness trials with real-world data are crucial for accurate Number Needed to Treat (NNT) calculations and wise healthcare resource allocation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action.

Journal of human hypertension·2007
Same author

Development of explicit criteria to measure adherence to hypertension guidelines.

Journal of human hypertension·2006
Same author

The paradigm has shifted to systolic blood pressure.

Journal of human hypertension·2004
Same author

Calcium antagonists in hypertension.

Blood pressure·2002
Same author

Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy.

American journal of hypertension·2002
Same author

Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease.

American heart journal·2001

Area of Science:

  • Medical research methodology
  • Clinical decision-making
  • Health economics

Background:

  • Current clinical practice relies on trial evidence, which may not align with real-world patient care outcomes.
  • The interpretation of clinical trial data and its quality can lead to suboptimal medical decisions.
  • The Number Needed to Treat (NNT) is a widely accepted metric, but its simplicity risks misuse in guiding care and resource allocation.

Purpose of the Study:

  • To highlight the potential flaws in using standard clinical trial data for real-world medical decisions.
  • To advocate for a revised approach to data collection for improved clinical decision-making.
  • To emphasize the need for accurate metrics to guide healthcare resource allocation.

Main Methods:

  • Critically evaluating the data underpinning the Number Needed to Treat (NNT) metric.

Related Experiment Videos

  • Proposing the use of effectiveness trials conducted in real-world settings with diverse patient populations.
  • Examining the utility of large, simple trials for generating applicable clinical data.

    • Main Results:

    • The simplicity of the NNT can be misleading if based on data not representative of actual clinical practice.
    • Suboptimal care and misguided healthcare resource allocation can result from flawed NNT calculations.
    • Effectiveness trials in real-world settings offer a more accurate reflection of treatment outcomes.

    Conclusions:

    • Real-world effectiveness trials are essential for generating accurate data for clinical decision-making.
    • Future trials, particularly for chronic conditions like hypertension, should adopt the real-world effectiveness paradigm.
    • Accurate data from real-world trials are necessary for informed healthcare reimbursement and resource management.